Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts

Bone Cysts Clinical Trial

Official title:
Evaluation of Faisability, Safety and Effectiveness and of Discogel in Patients With Aneurysmal and Simple Bone Cysts

Status Recruiting

Clinical Trial Summary

There is no consensus in the scientific literature for the treatment of aneurysmal and simple bone cysts. Some scientific articles with utilisation of sclerosis agents for the treatment of aneurysmal bone cysts: Ethibloc no longer marketed, pure Ethanol, Aetoxisclerol.

Clinical Trial Description

The aim of this work is therefore the evaluation of Discogel® in the treatment of Discogel®, which appears to be a safe and efficacity of method. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05880628
Study type	Observational
Source	Centre Hospitalier Universitaire de Saint Etienne
Contact	Sylvain Grange, MD
Phone	(0)477829066
Email	Sylvain.Grange@chu-st-etienne.fr
Status	Recruiting
Phase
Start date	April 14, 2022
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04737590` - Bioactive Glass or Allogenic Bone in Pediatric Bone Cysts	N/A
Completed	`NCT03076138` - Gene-activated Bone Substitute for Maxillofacial Bone Regeneration	N/A
Enrolling by invitation	`NCT05075148` - Aneurysmal Bone Cyst Imaging After Interventional Radiology Treatment
Withdrawn	`NCT00459641` - Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts	Phase 2